Myocardial FDG-PET examination during fasting and glucose loading states by means of a one-day protocol
- 59 Downloads
We propose a new method to measure the myocardial FDG uptake during fasting and glucose loading in one day, a myocardial FDG-PET one-day protocol, with both 2- and 3-dimensional data acquisition (2D and 3D) without background activity subtraction. To confirm it, we evaluated the effect of scatter correction in the 2D and 3D modes of a PET scanner both in phantom and patient studies. In the phantom study, we used a cardiac phantom with six divided chambers and two cylindrical phantoms placed as the activity outside the field of view. Each chamber was filled with a different concentration of F-18 solution. Regions of interest (ROI) were placed on a polar map generated from reconstructed images and were compared to the concentration of the solution in each chamber in both 2D and 3D. In the patient study, 10 non-diabetic patients with coronary artery disease were studied. Each patient received a myocardial FDG study during fasting (F) and glucose loading (L). L images with background subtraction (Lsub(+)) and without background subtraction (Lsub(−)) were compared by polar map analysis. The ROI counts for the true activity in 2D and 3D demonstrated a linear relationship, and quite similar slopes were observed (0.72 in 2D, 0.69 in 3D). The background fraction in Lsub(−) was 3.59±1.83%. There were significant differences between Lsub(−) or Lsub(+), and F in both normal and ischemic myocardium. Scatter correction was successfully performed in both 2D and 3D modes. Background activity is thought to be negligible and this proposed method is simple touse in measuring the myocardial FDG uptake in one day.
Key wordsFDG-PET fasting glucose loading 3-dimensional data acquisition
Unable to display preview. Download preview PDF.
- 1.Gropler RJ, Geltman EM, Sobel BE. Clinical application of cardiac positron emission tomography. In: Bergman SR, Sobel BE, eds.Positron Emission Tomography of the Heart. Mount Kisco, NY; Future Publishing, Inc., 1992; 255–292.Google Scholar
- 2.Lewellen TK, Kohlmyer SG, Miyaoka RS, Kaplan MS, Stearns CW, Schubert SF. Investigation of the performance of the General Electric ADVANCE positron emission tomograph in 3D mode.IEEE Trans 1996; 43: 2199–2206.Google Scholar
- 4.Prellwotz J, Vasta M, Sunderland J, Shuie C-Y, Gupta N, Frick M. Investigation of factors influencing FDG myocardial image quality. [Abstract]J Nucl Med 1991; 32: 1039.Google Scholar
- 6.Tamaki N, Yonekura Y, Kawamoto M, Magata Y, Sasayama S, Takahashi N, et al. Simple, quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition.J Nucl Med 1991; 33: 2152–2157.Google Scholar
- 9.Brunken R, Tillisch J, Schwaiger M, Child JS, Marshall R, Mandelkern M, et al. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography.Circulation 1986; 73: 951–963.PubMedGoogle Scholar
- 11.Niwayama H, Yoshida K, Kagaya A, Himi T, Masuda Y, Inagaki Y, et al. PET assessment of myocardial viability with glucose loading and fasting FDG images.KAKU IGAKU (Jpn J Nucl Med) 1990; 27: 285–288.Google Scholar